After eight weeks of treatment, 11 out of 12 patients showed a 20–80% improvement in the Psoriasis Area and Severity Index (PASI), which was accompanied by a decreased expression of pro-inflammatory cytokines, including IFN-γ, IL-8, IL-12, TNF-α, and IL-1β. This evidence concerns the gene CXCL8 and psoriasis.